SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-141442
Filing Date
2023-05-11
Accepted
2023-05-11 07:46:00
Documents
16
Period of Report
2023-05-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d467856d8k.htm   iXBRL 8-K 39543
2 EX-10.1 d467856dex101.htm EX-10.1 155805
3 EX-10.2 d467856dex102.htm EX-10.2 86855
4 EX-99.1 d467856dex991.htm EX-99.1 52899
8 GRAPHIC g467856g0511033428288.jpg GRAPHIC 2657
  Complete submission text file 0001193125-23-141442.txt   547590

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA fusn-20230510.xsd EX-101.SCH 2853
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE fusn-20230510_lab.xml EX-101.LAB 18689
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fusn-20230510_pre.xml EX-101.PRE 11694
10 EXTRACTED XBRL INSTANCE DOCUMENT d467856d8k_htm.xml XML 3517
Mailing Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6
Business Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6 289-799-0891
Fusion Pharmaceuticals Inc. (Filer) CIK: 0001805890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39344 | Film No.: 23908884
SIC: 2836 Biological Products, (No Diagnostic Substances)